secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cosmos Health Inc. (COSM)
CIK:        0001474167
Form:       8-K
Filed at:   2023-05-31T23:59:59+00:00
Accession:  0001477932-23-004119
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.45
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cosmos Health to acquire Docpharm GmbH for €800K cash plus €1M credit line
--------------------------------------------------------------------------

- Purchase price €800,000 in cash to Docpharm owners; additional €1,000,000 credit line for working capital.
- Closing subject to due diligence, definitive SPA, board/stockholder approvals, and PCAOB-auditable financials.
- Exclusivity through July 15, 2023; Docpharm is an ISO/GDP-certified German pharmaceutical distributor since 1995.
- Current managing directors to remain; new service agreements with equal or better economic terms.
- Cosmos to bear costs of due diligence and audit as part of the transaction.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1474167/000147793223004119/0001477932-23-004119-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1474167/000147793223004119/cosm_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-23-004119

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer